Glenmark in talks to sell up to 30% in API biz to PremjiInvest
Posted by
www.biotecnika.org
The pharma group plans to sell minority stake for $150m in their new
subsidiary of active pharmaceutical ingredient products. Discussions
are ongoing with True North
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-in-talks-to-sell-up-to-30-in-api-biz-to-premjiinvest/articleshow/70796601.cms
Subscribe to:
Post Comments (Atom)
Post a Comment